This promotes ROS generation, the upregulation of lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1), and endothelial dysfunction, thereby accelerating the progression of MetS and its associated complications [18]. The gene discussed is OLR1; the disease is metabolic syndrome.